MetLife Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Sell |
|
|||||
|
2025
Q1 | $3.63M | Sell |
|
|||||
|
2024
Q4 | $7.02M | Buy |
|
|||||
|
2024
Q3 | $6.66M | Sell |
|
|||||
|
2024
Q2 | $8.52M | Buy |
|
|||||
|
2024
Q1 | $704K | Buy |
|
|||||
|
2023
Q4 | $523K | Sell |
|
|||||
|
2023
Q3 | $666K | Buy |
|
|||||
|
2023
Q2 | $629K | Buy |
|
|||||
|
2023
Q1 | $703K | Buy |
|
|||||
|
2022
Q4 | $659K | Sell |
|
|||||
|
2022
Q3 | $577K | Buy |
|
|||||
|
2022
Q2 | $391K | Sell |
|
|||||
|
2022
Q1 | $421K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $10.8K | Hold |
|
|||||
|
2018
Q4 | $9.93K | Buy |
|
|||||
|
2018
Q3 | $14.1K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.05M | Hold |
|
|||||
|
2017
Q4 | $1.54M | Buy |
|